DSIJ Mindshare

Lupin receives tentative USFDA approval, stock tops Nifty pharma

Bhagyashree Vivarekar 0 1714 Article rating: 5.0

Lupin, the sixth largest pharma company by market capitalisation, received tentative US FDA approval for its generic Lurasidone Tablets of 20, 40, 60, 80 and 120 mg. Lupin which holds 8.8 per cent weightage in the Nifty pharma index was the top gainer in the index and surged 5 per cent on a closing basis. 

RSS
First54665467546854695471547354745475Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR